{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:26:39Z","timestamp":1789644399652,"version":"4.0.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamadermatol.2018.2549","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T12:36:47Z","timestamp":1535027807000},"page":"1199","source":"Crossref","is-referenced-by-count":48,"title":["Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis"],"prefix":"10.1001","volume":"154","author":[{"given":"Paige W.","family":"Wolstencroft","sequence":"first","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"dbr180015r1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"dbr180015r2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/archderm.141.7.855","article-title":"Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.","volume":"141","author":"Ang","year":"2005","journal-title":"Arch Dermatol"},{"issue":"9","key":"dbr180015r3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus.","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"issue":"7","key":"dbr180015r4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"dbr180015r5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"dbr180015r6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","article-title":"Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.","volume":"20","author":"Sontheimer","year":"2002","journal-title":"Dermatol Clin"},{"issue":"4","key":"dbr180015r7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjd.13915","article-title":"Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change.","volume":"173","author":"Anyanwu","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"dbr180015r8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamadermatol.2017.3758","article-title":"Factors associated with clinical remission of skin disease in dermatomyositis.","volume":"154","author":"Wolstencroft","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"11","key":"dbr180015r9","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1?.","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"dbr180015r10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: new mechanisms for old drugs.","volume":"68","author":"An","year":"2017","journal-title":"Annu Rev Med"},{"issue":"5","key":"dbr180015r11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/bjd.15006","article-title":"Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon \u00df in dermatomyositis.","volume":"176","author":"Huard","year":"2017","journal-title":"Br J Dermatol"},{"issue":"12","key":"dbr180015r12","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"dbr180015r13","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.","volume":"186","author":"Kuznik","year":"2011","journal-title":"J Immunol"},{"issue":"6121","key":"dbr180015r14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"9","key":"dbr180015r15","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.4049\/jimmunol.1402793","article-title":"Cutting edge: antimalarial drugs inhibit IFN-\u00df production through blockade of cyclic GMP-AMP synthase-DNA interaction.","volume":"194","author":"An","year":"2015","journal-title":"J Immunol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamadermatology\/fullarticle\/2697214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T16:09:14Z","timestamp":1539187754000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.2549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.2549","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}